The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...

I'll start by comparing the revenue growth rates of AbbVie and Sanofi, then move on to discuss how often these two leaders in the autoimmune disease treatment market beat Wall Street analysts ...

Regeneron (REGN) and Sanofi (SNY) announced that the Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent for the treatment of chronic ...

Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...

Questions or Comments about the article? Write to [email protected] Sanofi NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Sanofi estimates that the annual cost for a typical patient will be around $280,000 per year before discounts or rebates, in line with other drugs used to treat rare, chronic diseases.

President Donald Trump first told hospitals to put prices online in 2019 during his first administration and transparency rules for insurers soon followed, as the government sought to lower U.S ...

Then, in April 2023, #UniteBehind took the ethics committee to court for failing to act on the complaints. Calling for more transparency and an open public participation process, they wanted the code ...

These are the conclusions of the first edition of the Opacity in Real Estate Ownership (OREO) Index, by the Anti-Corruption Data Collective (ACDC) and Transparency International, published today. The ...

There’s a whole lot to admire in this project. The swing-out transparent OLED display is super slick, the electronics are housed on a single PCB, the back half of the grip is in fact a portable ...

Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1 ...